Hemispherectomy is required in most cases of hemimegalencephaly in order to control epilepsy refractory to medical treatment. Although there is a general agreement on the effectiveness of the procedure in controlling the seizure disorder, the choice of the surgical technique is still a subject of debate. In particular, anatomical hemispherectomy is blamed to be associated with a higher incidence of surgical complications, namely hydrocephalus and hemosiderosis, than other less ablative operations such as functional hemispherectomies. A series of 15 children with hemimegalencephaly, who had undergone anatomical hemispherectomy (11 cases), functional hemispherectomy (2 cases), and hemidecortication (2 cases) at the Pediatric Neurosurgery Section, Catholic University Medical School, Rome, is reported. Twelve of these patients presented with one or more complications in their postoperative course. Temporary complications, which resolved spontaneously or following medical therapy, included fever, wound breakdown, worsening of preoperative motor deficit, unilateral third cranial nerve deficit, dystonia, and anemia. In 8 patients, postoperative complications led to a second surgical procedure. A CSF shunt was necessary in 5 children, to control a secondary hydrocephalus. Two subjects underwent a toilette of the residual cavity because of persisting chemical abnormalities in CSF parameters. In a child a cranioplasty procedure was necessary as a consequence of an infection of the hemicranial bone flap. There was no apparent correlation between the rate and the type of complications with a specific surgical procedure. On the other hand, the age factor appeared to play an important role in the occurrence of secondary hydrocephalus, as all 5 children with this complication were less than 9 months old at the time of the hemispherectomy. Surgical mortality was nil in this series.

Keywords:
Hemimegalencephaly, Epilepsy, Anatomical hemispherectomy, Functional hemispherectomy, Hemicorticectomy, Hemidecortication, Surgical complications
1.
Peacock WJ, Webby-Grant MC, Shields WD, Shewmon DA, Chugani HT, Sankar R, Vinters HV: Hemispherectomy for intractable seizures in children: A report of 58 cases. Childs Nerv Syst 1996;12:376–384.
2.
Villemure JG: Cerebral hemispherectomy for epilepsy; in Schmidek HH, Sweet WH (eds): Operative Neurosurgical Techniques. Philadelphia, Saunders, 1995, pp 1341–1350.
3.
Oppenheimer DR, Griffith HB: Persistent intracranial bleeding as a complication of hemispherectomy. J Neurol Neurosurg Psychiatry 1966;9:229–240.
4.
Di Rocco C, Iannelli A, Marchese E, Vigevano F, Rossi GF: Terapia chirurgica dell’emimegalencefalia epilettogena. Minerva Pediatr 1994;46:231–237.
5.
Adams CBT: Hemispherectomy: A modification. J Neurol Neurosurg Psychiatry 1983;46:617–619.
6.
Villemure JD, Adams CBT, Hoffman JH, Peacock WJ: Hemispherectomy; in Engel J (ed): Surgical Treatment of Epilepsies. New York, Raven Press, 1993, pp 511–518.
7.
Winston KR, Welch K, Adler JR, Erba G: Cerebral hemicorticectomy for epilepsy. J Neurosurg 1992;77:889–895.
8.
Rasmussen T: Hemispherectomy for seizures revisited. Can J Neurol Sci 1983;10:71–78.
9.
Delalande O, Pinard JM, Basdevant C, et al: Hemispherotomy: A new procedure for central disconnection. Epilepsia 1992;33(suppl 3):99–100.
10.
Falconer MA, Wilson PJE: Complications related to delayed hemorrhage after hemispherectomy. J Neurosurg 1969;30:413–426.
11.
Rasmussen T: Post-operative superficial hemosiderosis of the brain. Its diagnosis, treatment and prevention. Am Neurol Assoc 1973;98:133–137.
12.
Schramm J, Behrens E, Entzian W: Hemispherical deafferentation: An alternative to functional hemispherectomy. Neurosurgery 1995;36:509–516.
13.
Kanev PM, Foley CM, Miles D: Ultrasound-tailored functional hemispherectomy for surgical control of seizures in children. J Neurosurg 1997;86:762–767.
14.
Wroe S, Richens A, Compston A: Bilateral ballistic movements occurring as a late complication of hemispherectomy and responding to sulpiride. J Neurol 1986;233:315–316.
15.
Moyes PD, Jenkins LC, Doll WA: Hemispherectomies with particular reference to anaesthetic management. BC Med J 1971;13:241–243.
16.
Strowitzki M, Kiefer M, Steudel WI: Acute hydrocephalus as a late complication of hemispherectomy. Acta Neurochir 1994;131:253–259.
17.
Davies KG, Maxwell RE, French LA: Hemispherectomy for intractable seizures: Long-term results in 17 patients followed for up to 38 years. J Neurosurg 1993;78:733–740.
18.
Carson BS, Javedan SP, Freeman JM, Vining EPG, Zuckerberg AL, Lauer JA, Guarnieri M: Hemispherectomy: A hemodecortication approach and review of 52 cases. J Neurosurg 1996;84:903–911.
19.
Sims JM: On hypertrophy and atrophy of the brain. Medicochir Trans 1835;19:315–380.
20.
Kalkanis SN, Blumenfeld H, Sherman JC, Krebs DE, Irizarry MC, Parker SW, Cosgrove GR: Delayed complications thirty-six years after hemispherectomy: A case report. Epilepsia 1996;37:758–762.
21.
Yasha TC, Santosh V, Shankar SK: Hemimegalencephaly – Morphological and immunocytochemical study. Appl Neuropathol 1997;16:17–22.
22.
Bianchine JW: The nevous sebaceous of Jadassohn. Am J Dis Child 1970;120:223–228.
23.
Cavenagh EC, Hart BL, Rose D: Association of linear sebaceous nevus syndrome and unilateral megalencephaly. AJNR 1993;14:405–408.
24.
Bosman C, Boldrini R, Dimitri L, Di Rocco C, Corsi A: Hemimegalencephaly. Histological, immunohistochemical, ultrastructural and cytofluorimetric study of six patients. Childs Nerv Syst 1996;12:765–775.
25.
Humbertelande VT, Coubes PA, Robain O, Echenne BB: Early hemispherectomy in a case of hemimegalencephaly. Pediatr Neurosurg 1997;27:268–271.
26.
Taha JM, Crone KR, Berger TS: The role of hemispherectomy in the treatment of holohemispheric hemimegalencephaly. J Neurosurg 1994;81:37–42.
27.
Battaglia D, Di Rocco C, Iuvone L, Acquafondata C, Iannelli A, Lettori D, Guzzetta F: Neurocognitive development and epilepsy outcome in children with surgically treated hemimegalencephaly. Neuropediatrics 1999;30:307–313.
28.
Myles ST, Darwish H, Hamilton MG, Lange VL: Complications of surgical management of hemimegalencephaly in childhood. Childs Nerv Syst 1998;14:679–682.
29.
Ogunmekan AO, Hwang PA, Hoffman HJ: Sturge-Weber-Dimitri disease: Role of hemispherectomy in prognosis. Can J Neurol Sci 1989;16:78–80.
30.
Villemure JG, Mascott CR: Peri-insular hemispherotomy: Surgical principles and anatomy. Neurosurgery 1995;37:975–981.
31.
Freeman JM, Vining EPG, Carson B, Zuckerberg A: Hemispheric deafferentation: An alternative to functional hemispherectomy. Neurosurgery 1996;39:622.
32.
Velardi F, Di Chirico A, Di Rocco C, et al: ‘No allogeneic blood transfusion’ protocol for the surgical correction of craniosynostoses. II. Clinical application. Childs Nerv Syst 1998;14:732–739.
33.
Dandy WE: Removal of right cerebral hemisphere for certain tumors with hemiplegia. Preliminary report. JAMA 1928;90:823–825.
34.
White HH: Cerebral hemispherectomy in the treatment of infantile hemiplegia. Review of the literature and report of two cases. Confinia Neurol 1961;21:1–50.
35.
Wilson PJE: Cerebral hemispherectomy for infantile hemiplegia. A report of 50 cases. Brain 1970;93:147–180.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.